Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1997 1
1998 2
1999 1
2000 3
2001 7
2002 3
2003 2
2004 2
2005 3
2006 6
2007 3
2008 1
2009 4
2010 1
2011 1
2012 1
2013 1
2014 1
2015 5
2016 2
2018 7
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Robak T, Jin J, Pylypenko H, Verhoef G, Siritanaratkul N, Drach J, Raderer M, Mayer J, Pereira J, Tumyan G, Okamoto R, Nakahara S, Hu P, Appiani C, Nemat S, Cavalli F; LYM-3002 investigators. Robak T, et al. Lancet Oncol. 2018 Nov;19(11):1449-1458. doi: 10.1016/S1470-2045(18)30685-5. Epub 2018 Oct 19. Lancet Oncol. 2018. PMID: 30348538 Clinical Trial.
Bortezomib-induced skin lesion.
Ozcan MA, Alacacioglu I, Piskin O, Lebe B, Turgut N, Ceneli S, Demirkan F, Ozsan GH, Undar B. Ozcan MA, et al. Among authors: undar b. Acta Haematol. 2006;116(3):226-7. doi: 10.1159/000094689. Acta Haematol. 2006. PMID: 17016047 No abstract available.
Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
Robak T, Huang H, Jin J, Zhu J, Liu T, Samoilova O, Pylypenko H, Verhoef G, Siritanaratkul N, Osmanov E, Alexeeva J, Pereira J, Drach J, Mayer J, Hong X, Okamoto R, Pei L, Rooney B, van de Velde H, Cavalli F; LYM-3002 Investigators. Robak T, et al. N Engl J Med. 2015 Mar 5;372(10):944-53. doi: 10.1056/NEJMoa1412096. N Engl J Med. 2015. PMID: 25738670 Free article. Clinical Trial.
History repeats itself: horse originated hyperimmune sera production against SARS CoV-2.
Pakdemirli A, Çalışkan E, Hacıoğlu S, Danyer E, Kardoğan Ö, Kurt ZE, Yıldırım Ö, Taşkaya H, Ündar B, Sezgin Y, Ergin G, Ekici H, Ülker U, Taçbaş E, Çakır Ş, Bülbül R, Bebek M, Sarper M, Dülger D, Sarı ÜS, Ergin F, Kabaklı Ö, Yaralı C. Pakdemirli A, et al. Among authors: undar b. Turk J Med Sci. 2021 Oct 21;51(5):2263-2273. doi: 10.3906/sag-2101-304. Turk J Med Sci. 2021. PMID: 34092050 Free article.
IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort.
Sevindik OG, Mersin S, Katgi A, Tunali S, Solmaz SM, Acar C, Alacacioglu I, Piskin O, Ozcan MA, Demirkan F, Undar B, Ozsan GH. Sevindik OG, et al. Among authors: undar b. Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):e101-4. doi: 10.1016/j.clml.2015.02.004. Epub 2015 Feb 11. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25790738
Platelet activation in congenital heart diseases.
Olgun N, Uysal KM, Irken G, Unal N, Undar B, Akkoç N, Akçoral A, Sarialioğlu F, Cevik N. Olgun N, et al. Among authors: undar b. Acta Paediatr Jpn. 1997 Oct;39(5):566-9. doi: 10.1111/j.1442-200x.1997.tb03642.x. Acta Paediatr Jpn. 1997. PMID: 9363654
Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
Solmaz S, Uzun O, Acar C, Sevindik OG, Piskin O, Ozsan HG, Demirkan F, Undar B, Alacacioglu A, Ozcan MA, Alacacioglu I. Solmaz S, et al. Among authors: undar b. J Lab Physicians. 2018 Oct-Dec;10(4):363-369. doi: 10.4103/JLP.JLP_36_18. J Lab Physicians. 2018. PMID: 30498304 Free PMC article.
Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?
Solmaz Medeni Ş, Türkyılmaz D, Acar C, Sevindik ÖG, Yüksel F, Pişkin Ö, Özcan MA, Demirkan F, Ündar B, Alacacıoğlu İ, Özsan GH. Solmaz Medeni Ş, et al. Among authors: undar b. Turk J Haematol. 2018 Nov 13;35(4):271-276. doi: 10.4274/tjh.2018.0071. Epub 2018 Jun 20. Turk J Haematol. 2018. PMID: 29923493 Free PMC article.
62 results